Stephen T Wright1, Jennifer Hoy, Brian Mulhall, Catherine C Oʼconnor, Kathy Petoumenos, Timothy Read, Don Smith, Ian Woolley, Mark A Boyd. 1. *The Kirby Institute, University of New South Wales, Sydney, Australia; †Department of Medicine, Monash University, Melbourne, Australia; ‡Infectious Diseases Unit, The Alfred Hospital, Melbourne, Australia; §School of Public Health, University of Sydney, Sydney, Australia; ‖RPA Sexual Health, Royal Prince Alfred Hospital, Sydney, Australia; ¶Central Clinical School, University of Sydney, Sydney, Australia; #Melbourne Sexual Health Center, The Alfred Hospital, Melbourne, Australia; **The Albion Center, Sydney, Australia; ††School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia; and ‡‡Infectious Diseases, Monash Medical Centre, Melbourne, Australia.
Abstract
BACKGROUND: Recent studies suggest higher cumulative HIV viremia exposure measured as viremia copy-years (VCY) is associated with increased all-cause mortality. The objectives of this study are (1) report the association between VCY and all-cause mortality and (2) assess associations between common patient characteristics and VCY. METHODS: Analyses were based on patients recruited to the Australian HIV Observational Database (AHOD) who had received ≥24 weeks of antiretroviral therapy (ART). We established VCY after 1, 3, 5, and 10 years of ART by calculating the area under the plasma viral load time series. We used survival methods to determine the association between high VCY and all-cause mortality. We used multivariable mixed-effect models to determine predictors of VCY. We compared a baseline information model with a time-updated model to evaluate discrimination of patients with high VCY. RESULTS: Of the 3021 AHOD participants who initiated ART, 2073 (69%), 1667 (55%), 1267 (42%), and 638 (21%) were eligible for analysis at 1, 3, 5, and 10 years of ART, respectively. Multivariable-adjusted hazard ratio association between all-cause mortality and high VCY was statistically significant, hazard ratio 1.52 (1.09, 2.13), P = 0.01. Predicting high VCY after 1 year of ART for a time-updated model compared with a baseline information model, the area under the sensitivity/specificity curve was 0.92 vs. 0.84; and at 10 years of ART, area under the sensitivity/specificity curve was 0.87 vs. 0.61, respectively. CONCLUSION: A high cumulative measure of viral load after initiating ART is associated with increased risk of all-cause mortality. Identifying patients with high VCY is improved by incorporating time-updated information.
BACKGROUND: Recent studies suggest higher cumulative HIV viremia exposure measured as viremia copy-years (VCY) is associated with increased all-cause mortality. The objectives of this study are (1) report the association between VCY and all-cause mortality and (2) assess associations between common patient characteristics and VCY. METHODS: Analyses were based on patients recruited to the Australian HIV Observational Database (AHOD) who had received ≥24 weeks of antiretroviral therapy (ART). We established VCY after 1, 3, 5, and 10 years of ART by calculating the area under the plasma viral load time series. We used survival methods to determine the association between high VCY and all-cause mortality. We used multivariable mixed-effect models to determine predictors of VCY. We compared a baseline information model with a time-updated model to evaluate discrimination of patients with high VCY. RESULTS: Of the 3021 AHOD participants who initiated ART, 2073 (69%), 1667 (55%), 1267 (42%), and 638 (21%) were eligible for analysis at 1, 3, 5, and 10 years of ART, respectively. Multivariable-adjusted hazard ratio association between all-cause mortality and high VCY was statistically significant, hazard ratio 1.52 (1.09, 2.13), P = 0.01. Predicting high VCY after 1 year of ART for a time-updated model compared with a baseline information model, the area under the sensitivity/specificity curve was 0.92 vs. 0.84; and at 10 years of ART, area under the sensitivity/specificity curve was 0.87 vs. 0.61, respectively. CONCLUSION: A high cumulative measure of viral load after initiating ART is associated with increased risk of all-cause mortality. Identifying patients with high VCY is improved by incorporating time-updated information.
Authors: Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger Journal: Int J Epidemiol Date: 2009-10-09 Impact factor: 7.196
Authors: Alexander Zoufaly; Hans-Jürgen Stellbrink; Matthias An der Heiden; Christian Kollan; Christian Hoffmann; Jan van Lunzen; Osamah Hamouda Journal: J Infect Dis Date: 2009-07-01 Impact factor: 5.226
Authors: W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport Journal: N Engl J Med Date: 2006-11-30 Impact factor: 91.245
Authors: Hamish McManus; Catherine C O'Connor; Mark Boyd; Jennifer Broom; Darren Russell; Kerrie Watson; Norman Roth; Phillip J Read; Kathy Petoumenos; Matthew G Law Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240
Authors: Jeffrey W Eaton; Leigh F Johnson; Joshua A Salomon; Till Bärnighausen; Eran Bendavid; Anna Bershteyn; David E Bloom; Valentina Cambiano; Christophe Fraser; Jan A C Hontelez; Salal Humair; Daniel J Klein; Elisa F Long; Andrew N Phillips; Carel Pretorius; John Stover; Edward A Wenger; Brian G Williams; Timothy B Hallett Journal: PLoS Med Date: 2012-07-10 Impact factor: 11.069
Authors: Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook Journal: Curr HIV Res Date: 2020 Impact factor: 1.581
Authors: Joseph B Sempa; Jonathan Dushoff; Michael J Daniels; Barbara Castelnuovo; Agnes N Kiragga; Martin Nieuwoudt; Steven E Bellan Journal: Am J Epidemiol Date: 2016-05-04 Impact factor: 4.897
Authors: Murli U Purswani; Kunjal Patel; Cheryl A Winkler; Stephen A Spector; Rohan Hazra; George R Seage; Lynne Mofenson; Brad Karalius; Gwendolyn B Scott; Russell B Van Dyke; Jeffrey B Kopp Journal: J Acquir Immune Defic Syndr Date: 2016-09-01 Impact factor: 3.731
Authors: Jordan E Cates; Daniel Westreich; Andrew Edmonds; Rodney L Wright; Howard Minkoff; Christine Colie; Ruth M Greenblatt; Helen E Cejtin; Roksana Karim; Lisa B Haddad; Mirjam-Colette Kempf; Elizabeth T Golub; Adaora A Adimora Journal: Infect Dis Obstet Gynecol Date: 2015-10-25
Authors: Ashley D Olson; A Sarah Walker; Amitabh B Suthar; Caroline Sabin; Heiner C Bucher; Inma Jarrin; Santiago Moreno; Santiago Perez-Hoyos; Kholoud Porter; Deborah Ford Journal: J Acquir Immune Defic Syndr Date: 2016-09-01 Impact factor: 3.731